Pharmacogenetic Trial of Doxazosin for Treatment of Cocaine Abuse

NCT01953432 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

FED

Sponsor class

Conditions

Cocaine Dependence

Interventions

DRUG: Doxazosin
DRUG: Placebo

Sponsor

VA Office of Research and Development

Collaborators

[object Object]